Lenalidomide following whole‐brain radiotherapy in patients with primary central nervous system lymphoma ineligible for intensive systemic therapy
British Journal of Haematology · 2023
DOI: 10.1111/bjh.18659 ↗Kurz gefasst
Leserbrief in der Zeitschrift British Journal of Haematology, 2023. Verfasst von Bhausaheb Bagal und 14 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology, Tata Memorial Centre, Mumbai, India. Hauptthemen laut MEDLINE: Lymphoma, Non-Hodgkin, Central Nervous System Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical Oncology, Tata Memorial Centre, Mumbai, India.
- Homi Bhabha National Institute, Mumbai, India.
- Radiation Oncology, Tata Memorial Centre, Mumbai, India.
- Pathology, Tata Memorial Centre, Mumbai, India.
ORCID-Profile: Bhausaheb Bagal, Rup Sarma, Lingaraj Nayak, Jayant Goda, Hasmukh Jain, Manju Sengar, Tejpal Gupta
Zitieren
APA
Bagal, B., Sarma, R., Dey, S., Nayak, L., Bonda, A., Goda, J., Khanna, N., Dasgupta, A., Kakoti, S., Chatarjee, A., Jain, H., Epari, S., Laskar, S., Sengar, M., & Gupta, T. (2023). Lenalidomide following whole‐brain radiotherapy in patients with primary central nervous system lymphoma ineligible for intensive systemic therapy. British Journal of Haematology. https://doi.org/10.1111/bjh.18659
Vancouver
Bagal B, Sarma R, Dey S, Nayak L, Bonda A, Goda J, et al. Lenalidomide following whole‐brain radiotherapy in patients with primary central nervous system lymphoma ineligible for intensive systemic therapy. British Journal of Haematology. 2023. doi:10.1111/bjh.18659
BibTeX
@article{Bagal2023,
author = {Bagal, Bhausaheb and Sarma, Rup and Dey, Sayak and Nayak, Lingaraj and Bonda, Avinash and Goda, Jayant and Khanna, Nehal and Dasgupta, Archya and Kakoti, Sangeeta and Chatarjee, Abhishek and Jain, Hasmukh and Epari, Sridhar and Laskar, Siddhartha and Sengar, Manju and Gupta, Tejpal},
title = {Lenalidomide following whole‐brain radiotherapy in patients with primary central nervous system lymphoma ineligible for intensive systemic therapy},
journal = {British Journal of Haematology},
year = {2023},
doi = {10.1111/bjh.18659}
}
EUVIMED